Table 3.
The details of TEVAR procedure grouped by NLR value < 4.8 and ≥ 4.8
| Variable | Overall | Low NLR (< 4.8) |
High NLR (≥ 4.8) |
Standardized difference | P value |
|---|---|---|---|---|---|
| Length of hospital stay (days) | 10 (8–14) | 10 (7–14) | 10 (9–15) | 0.24 | 0.076 |
| Timing of procedure | 0.05 | 0.713 | |||
| Acute phase | 126 (58.3 %) | 64 (57.1 %) | 62 (59.6 %) | ||
| Subacute phase | 90 (41.7 %) | 48 (42.9 %) | 42 (40.4 %) | ||
| ASA Classification | 0.24 | 0.205 | |||
| I | 68 (31.5 %) | 33 (29.4 %) | 35 (33.7 %) | ||
| II | 140 (64.8 %) | 77 (68.8 %) | 63 (60.6 %) | ||
| III | 8 (3.7 %) | 2 (1.8 %) | 6 (5.7 %) | ||
| Length of procedure (minutes) | 95(75–110) | 95(80–122) | 85(72–105) | 0.31 | 0.025 |
| Types of stentgraft | |||||
| Cook Zenith | 93 (43.1 %) | 48 (42.9 %) | 45 (43.3 %) | 0.4 | 0.044 |
| Gore TAG | 54 (25.0 %) | 33 (29.4 %) | 21 (20.2 %) | ||
| Medtronic Valiant | 55 (25.5 %) | 21 (18.8 %) | 34 (32.7 %) | ||
| Microport Hercules | 14 (6.4 %) | 10 (8.9 %) | 4 (3.9 %) | ||
| Adjunctive stents | 27 (12.5 %) | 15 (13.4 %) | 12 (11.5 %) | 0.06 | 0.681 |
Values are median (25th–75th percentile) or n (%)
TEVAR thoracic endovascular aortic repair, NLR neutrophil-to-lymphocyte ratio, ASA American Society of Anesthesiologists